#Unfolder dlbcl trial trial#

Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, et al. doi: Crossref Medline ISI, Google Scholarħ.

Early positron emission tomography Response-Adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial. André MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, et al. doi: Crossref Medline ISI, Google ScholarĦ.

#Unfolder dlbcl trial trial#

Results of a trial of PET-directed therapy for early-stage hodgkin’s lymphoma. Radford J, Illidge T, Counsell N, Hancock B, Pettengell R, Johnson P, et al.

doi: Crossref Medline ISI, Google Scholarĥ. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. doi: Crossref Medline ISI, Google ScholarĤ. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Barrington SF, Qian W, Somer EJ, Franceschetto A, Bagni B, Brun E, et al. doi: Crossref Medline ISI, Google Scholarģ. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on malignant lymphomas imaging Working group.

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. doi: Crossref Medline ISI, Google ScholarĢ. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging Subcommittee of international harmonization project in lymphoma. Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al.